Unclaimed Scholar Profile
Are you Paul Ruff? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at South African Medical Research CouncilASIDASID-3283-3398-2043 orcid.org/0000-0003-1055-1730
Paul Ruff
South African Medical Research Council•South Africa
Faculty researcher at South African Medical Research Council (ZA), specializing in Social Sciences & Humanities. [Discipline: Social Sciences & Humanities] [Scholar Type: Journal Research Scientist] [Career Tier: Distinguished Scholar] [Region: Southern Africa]
#Colorectal Cancer Treatments and Studies#Colorectal Cancer Surgical Treatments#Viral-associated cancers and disorders#Lung Cancer Treatments and Mutations
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 24,465 | 11,743 |
| h-index | 42 | 32 |
| i10-index | 108 | 76 |
Annual Citation Growth
Verified Citations / Year0
20201.2k
2021+40%1.6k
2022+29%2.1k
2023+33%2.8k
2024-8%2.6k
2025-45%1.4k
2026Scholarship Distribution & Proportions236 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (20,061) • 18% Global Research Impact (4,404)
236 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (236)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Published in New England Journal of Medicine•2009
DOI: 10.1056/nejmoa0805019 Verified Peer-Reviewed
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Published in The Lancet•2019
DOI: 10.1016/s0140-6736(19)32591-7 Verified Peer-Reviewed
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Published in The Lancet•2019
DOI: 10.1016/s0140-6736(18)32409-7 Verified Peer-Reviewed
Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Published in New England Journal of Medicine•2013
DOI: 10.1056/nejmoa1305275 Verified Peer-Reviewed
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Published in Journal of Clinical Oncology•2010
DOI: 10.1200/jco.2009.27.4860 Verified Peer-Reviewed
Showing 1 – 5 of 236 publications
1 / 48